Cell Culture Market Worth $48.63 Billion by 2029

According to a new market research report titled, ‘Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, Academic) – Global Forecast to 2029,’ published by Meticulous Research®, the cell culture market is expected to grow at a CAGR of 11.7% from 2022 to 2029, to reach $48.63 billion by 2029.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4788

A major factor contributing to the growth of this market is the increasing prevalence of chronic diseases. Hence, research studies are carried out for the treatment of these diseases. The drug development-related research studies involve cell culture techniques. Furthermore, the aging population increases the chances of age-related chronic diseases, further driving the market growth.

Additionally, there has been an increase in the adoption of single-use technology due to its advantages compared to other conventional technology, such as pre-sterilized condition, no post-process cleaning of the system, and less contamination. These factors further propel the demand for cell culture products.

Additionally, the growing adoption of 3D cell culture and the growth potential of personalized medicine are expected to offer significant growth opportunities for the players operating in the cell culture market.

The cell culture market is segmented by product [consumables (media {cell culture media, by physical form–dry powder media, liquid media}, {cell culture media, by type–off-the-shelf media, custom media}, {cell culture media; source-chemically defined media, serum-free media, classical media, xeno-free/animal component free, other cell culture media}), reagents (growth factors and cytokines, cryoprotective reagents, antibiotics/ antimycotics, cell dissociation reagents, buffers, balanced salt solutions, attachment and matrix factors, other cell culture reagents), cells and cell lines, sera (fetal bovine serum, other sera), cell culture vessels (cell culture dishes, cell culture plates, cell culture flasks, roller bottles, other cell culture vessels)) equipment (cryopreservative containers, refrigerators and freezers, biosafety cabinets, incubators, sterilizers, bioreactors, microscopes, centrifuges, cell counters, water baths, other equipment)]; application [bioproduction (monoclonal antibody production, therapeutic protein production, vaccine production, cell and gene therapy)], diagnostics, cancer research, drug screening and development, stem cell research); end user (pharmaceutical and biotechnology companies, academic and research institutes, diagnostic laboratories); and geography (North America, Europe, Asia-Pacific, Latin America, and MEA). The study also evaluates industry competitors and analyzes their market shares at country and regional levels.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=4788

Based on product, in 2022, the consumables segment is estimated to account for the largest share of the cell culture market. The segment is also expected to register the highest CAGR during the forecast period. The major factor contributing to the segment’s lucrative growth is the adoption of cell culture techniques for various applications in the life science sectors such as cancer research, stem cell research, bioproduction, and diagnosis. Hence, the recurrent use of consumables for research studies and production facilities.

Based on application, the bioproduction segment is expected to register the highest CAGR during the forecast period. Bioproduction includes monoclonal antibody production, therapeutic protein production, vaccine production, and cell and gene therapy. These applications are gaining popularity due to their effectiveness in treating diseases. Moreover, vaccine production was at a higher rate during the pandemic. Due to their effectiveness, an increase in approvals for monoclonal antibodies was also observed during the pandemic, contributing to the growth of this segment.

Quick Buy – Cell Culture Market Research Report: https://www.meticulousresearch.com/Checkout/94004198

Based on end user, the pharmaceutical and biotechnology companies segment is expected to register the highest growth rate during the forecast period. The major factor contributing to the growth of this segment is the rise in R&D spending of these companies for drug discovery and developments, vaccine production, and cancer cells. Additionally, these companies use cell culture products to produce biomolecules, further leading to market growth.

Based on geography, Asia-Pacific is expected to register the highest growth rate during the forecast period. Major factors contributing to the growth of this segment are the expansion of the biopharma and pharma companies in the region, an increase in the funding for research studies, and the growing number of clinical research activities.

Some of the key players operating in the cell culture market are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Cytiva (U.S.), Lonza Group Ltd (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Miltenyi Biotec B.V. & Co. KG (Germany), and Solida Biotech GmbH (Germany).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/cell-culture-market-4788

Scope of the Report:

Cell Culture Market, by Product

• Consumables
  • Media
    • Cell Culture Media Market, by Physical Form
      • Dry Powder Media
      • Liquid Media
    • Cell Culture Media Market, by Type
      • Off-the-Shelf Media
      • Custom Media
    • Cell Culture Media Market, by Source
      • Chemically Defined Media
      • Serum-free Media
      • Classical Media
      • Xeno-free/Animal Component Free
      • Other Cell Culture Media
  • Reagents
    • Growth Factors and Cytokines
    • Cryoprotective Reagents
    • Antibiotics/ Antimycotics
    • Cell Dissociation Reagents
    • Buffers
    • Balanced Salt Solutions
    • Attachment and Matrix Factors
    • Other Cell Culture Reagents

                    (Other cell culture reagents include chelators, antioxidants, sugars, vitamins, stains, and dyes)

• • Cells and Cell Lines
  • Sera
    • Fetal Bovine Serum
    • Other Sera

                    (Other sera include newborn calf serum, chicken serum, goat serum, rabbit serum, pig serum, mouse serum, sheep serum, rat serum, and horse serum)

• • Cell Culture Vessels
    • Cell Culture Dishes
    • Cell Culture Plates
    • Cell Culture Flasks
    • Roller Bottles
    • Other Cell Culture Vessels

                    (Other cell culture vessels include pipettes, tips, cuvettes, and tubings)

• Equipment
  • Cryopreservative Containers
  • Refrigerators and Freezers
  • Biosafety Cabinets
  • Incubators
  • Sterilizers
  • Bioreactors
  • Microscopes
  • Centrifuges
  • Cell Counters
  • Water Baths
  • Other Equipment

               (Other equipment includes scales, weighing balance, and pH meter)

Cell Culture Market, by Application

• Bioproduction
  • Monoclonal Antibody Production
  • Therapeutic Protein Production
  • Vaccine Production
  • Cell and Gene therapy
• Diagnostics
• Cancer Research
• Drug Screening and Development
• Stem Cell Research

Cell Culture Market, by End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Diagnostic Laboratories

Cell Culture Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4788

Diabetes Care Devices Market Worth $31.9 Billion by 2028 – Exclusive Report by Meticulous Research®

 According to a new market research report, titled “Diabetes Care Devices Market by Type [Diabetes Monitoring (CGM, Test Strips, Self-Monitoring Blood Glucose Meters, Lancets, Haemoglobin A1C Testing Kits)], [Insulin Delivery (Syringes, Pens, Pumps, Jet Injectors)] – Global Forecast to 2028” published by Meticulous Research®, the diabetes care devices market is expected to grow at a CAGR of 6.7% from 2021 to reach $31.9 billion by 2028.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3438

As the prevalence of diabetes is increasing globally, self-management of diabetic treatments has become necessary to avoid long-term complications and fatalities. Diabetes care devices play an important role in managing diabetes as they enable patients to record and track their blood glucose levels all day long and administer the insulin doses according to the insulin levels.

The key factors driving the overall diabetes care devices market are the rising obesity cases, unhealthy and sedentary lifestyle, increasing prevalence of diabetes, and development of new insulin delivery systems. However, some limitations of diabetes care devices are their high costs and accessibility in low-middle income countries.

Impact of COVID-19 on Diabetes Care Devices Market

The COVID-19 pandemic has severely impacted the diabetes care devices market. COVID-19 patients had higher blood glucose levels due to the use of steroids for the COVID-19 treatment. In 2020, the increase in the number of individuals suffering from diabetes due to COVID-19 expanded the income of the central participants in the diabetes care division. Many players in the market presented new progressed diabetes care devices and association arrangements for diabetes care devices.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=3438

Diabetes Care Devices Market Overview

The diabetes care devices market is segmented based on type: (diabetes monitoring devices and insulin delivery devices) and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).  The study also evaluates industry competitors and analyzes their market share at a global level.

In 2021, the diabetes monitoring devices segment is estimated to account for the largest share of the overall diabetes care devices market. This is mainly attributed to the increased adoption of test strips and self-monitoring blood glucose meters and increasing demand for continuous glucose monitoring with rising awareness towards the disease in developing countries. Diabetes monitoring devices can be utilized to monitor blood glucose values and help the patient adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a regular basis.

Diabetes monitoring devices are further segmented into continuous blood glucose monitoring devices, test strips, lancets, self-monitoring blood glucose meters, and hemoglobin A1C testing kits. The test strips segment is expected to dominate the diabetes monitoring devices market in 2021, primarily due to the frequent usage of test strips for both continuous and self-glucose monitoring and is widely used by patients in developing countries.

Moreover, insulin delivery devices also are further segmented into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. In 2021, the insulin pens segment is expected to dominate the insulin delivery devices market. This can be primarily attributed to its advantages over traditional syringe insulin delivery methods, including improved patient satisfaction and adherence, user-friendly, greater ease of use, superior accuracy for delivering small insulin doses, greater social acceptability, and less reported injection pain. However, insulin pumps are the fastest-growing segment due to the advantages such as predictable insulin delivery, precise delivery of insulin, and reduction of wide fluctuation in blood glucose. It also mimics the normal pancreas’s release of insulin.

Quick Buy – Diabetes Care Devices Market Research Report: https://www.meticulousresearch.com/Checkout/33395503

Geographically, in 2021, North America is estimated to account for the largest share of the global diabetes care devices market, followed by Europe and Asia-Pacific. Factors such as the increasing prevalence of diabetes with the rising need to self-monitor and treat the disease, increasing prevalence of major risk factors of diabetes such as obesity and sedentary lifestyle, increasing geriatric population, and growing government initiatives promoting diabetes care are driving the growth of the diabetes care devices market in North America. However, Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in this market is expected to be driven by the increasing prevalence of diabetes with the rising need to self-monitor the treatments, increasing prevalence of obesity and sedentary lifestyle, growing geriatric population, and government initiatives promoting diabetes care.

The report also includes an extensive assessment of the key strategic developments of leading market participants in the industry over the past four years. In recent years, the diabetes care devices market has witnessed several new product launches, approvals, agreements, collaborations, partnerships, expansions, and acquisitions. For instance, in May 2021, Medtronic PLC (Ireland) received CE Mark approval for the expanded functionality of its InPen and Guardian 4 sensors. Moreover, in February 2020, Abbott Laboratories (U.S.) partnered with Insulet Corporation (U.S.) to combine its leading continuous glucose monitoring (CGM) technology with Insulet’s Omnipod Horizon Automated Insulin Delivery System.

Some of the key players operating in the global diabetes care devices market are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), LifeScan IP Holdings, LLC (U.S.), Medtronic PLC (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Sanofi AS (France), and DexCom, Inc. (U.S.), among others.

The diabetes care devices market is dominated by Abbott Laboratories (U.S.), Medtronic PLC (Ireland), DexCom, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Ascensia Diabetes Care (Switzerland), LifeScan IP Holding, LLC (U.S.), Becton, Dickinson and Company (U.S.), Insulet Corporation (U.S.), Novo Nordisk A/S (Denmark), and Tandem Diabetes Care, Inc. (U.S.). Together, these companies held around 80% share of the global diabetes care devices market in 2020.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/diabetes-care-devices-market-3438

Scope of the Report:

Diabetes Care Devices Market, by Type

• Diabetes Monitoring Devices
• Insulin Delivery Devices

Diabetes Care Devices Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3438

Disinfection Robots Market Growing at a CAGR of 30.1% to Reach 2.79 Billion by 2028

 In its latest publication on the disinfection robots market, Meticulous Research®, states that the global disinfection robots market is expected to grow at a CAGR of 30.1% from 2021 to 2028 to reach $2.79 billion.

This market is driven by the increasing prevalence of hospital-acquired infections and the advantages offered by disinfection robots over manual disinfection. Furthermore, emerging economies and technological advancements in the field of robotics are expected to provide the industry with significant potential prospects in the future. However, the limitations of disinfection robots may hinder the growth of this market. Also, the high initial investment coupled with additional repair & maintenance costs poses a major challenge for the growth of this market.

Get Inside Scoop Of The Report, Download For Free Sample PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5234

To provide efficient analysis, Meticulous Research® has segmented this market based on type, technology, end user, and geography. The study also evaluates industry competitors and analyzes the market at the country level.

In 2021, based on type, the ultraviolet light disinfection robots segment is estimated to account for the largest share of the market. The large market share of this segment is attributed to the advantages of ultraviolet light disinfection robots in disinfecting hospital rooms with great efficiency and minimal need for manual intervention.

Request Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5234

In 2021, based on technology, the fully autonomous disinfection robots segment is estimated to account for the largest share of the overall market. The large market share of this segment is attributed to the technologically advanced features of fully autonomous disinfection robots, with self-navigation and smart decision-making capabilities.

The report provides competitive intelligence in terms of financials, growth strategies, type, technology, end user, and geographical presence on some of the key players in this market, including SESTO Robotics Pte. Ltd. (Singapore), UVD Robots (Denmark), PDI, Inc. (U.S.), Xenex Disinfection Services Inc. (U.S.), Nevoa Inc. (U.S.), Badger Technologies LLC (U.S.), Skytron, LLC (U.S.), Omron Corporation (Japan), Fetch Robotics, Inc. (U.S.), Finsen Technologies Ltd (U.K.), Taimi Robotics Technology Co. Ltd (China), Akara Robotics Ltd. (Ireland), Siemens AG (Germany), and Milagrow Business & Knowledge Solutions (Pvt.) Limited (India).

Speak to our Analysts to Understand the In Detail Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5234

Plasma Fractionation Market Worth $46.9 Billion by 2029

 

 

According to a new market research report, “Plasma Fractionation Market by Product [Immunoglobulins (Intravenous, Subcutaneous), Coagulation Factors, Albumin], Application (Immunology, Hematology, Neurology), and End User (Hospital, Clinical Research Lab, Academic Institutes) — Global Forecast to 2029”, published by Meticulous Research®, the plasma fractionation market is expected to grow at a CAGR of 7.1% from 2022 to reach $46.9 billion by 2029.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5117

Some of the key players operating in this market are CSL Limited (Australia), Grifols, S.A. (Spain), Octopharma AG (Switzerland), Kedrion S.P.A. (Italy), Shire plc (U.K.), Biotest AG (Germany), China Biologic Products Holdings, Inc. (China), Bio Products Laboratory Ltd (U.K.), Japan Blood Products Organization (Japan), and Intas Pharmaceuticals Ltd. (India).

The report also includes an extensive assessment of the product portfolio, geographic analysis, and key strategic developments in the industry’s leading market participants over the past four years (2019–2022). In recent years, the plasma fractionation market has witnessed several product approvals, new product launches, partnerships, agreements, & collaborations, expansions, and acquisitions. For instance, in February 2022, Grifols, S.A. (Spain) entered into an agreement with Endpoint Health, Inc. (U.S.) to develop and commercialize an Antithrombin III (AT-III) therapy to treat Sepsis. Also, in August 2021, Octopharma AG (Switzerland) received U.S. FDA approval for Octagam 10% [Immune Globulin Intravenous (Human)] for the treatment of adult dermatomyositis (DM).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/plasma-fractionation-market-5117

Scope of the Report:

Plasma Fractionation Market, by Product

• Immunoglobulins
• Intravenous Immunoglobulins
• Subcutaneous Immunoglobulins
• Intramuscular Immunoglobulins
•  
• Coagulation Factors
• Albumin
• Protease Inhibitors
• Others

Note: Other plasma-derived products include fibrin, sealant, and plasma.

Plasma Fractionation Market, by Application

• Immunology
• Hematology
• Neurology
• Critical Care
• Hemato-Oncology
• Rheumatology
• Others

Note: Other applications include management of respiratory diseases and wound healing.

Plasma Fractionation Market, by End User

• Hospitals& Clinics
• Clinical Research Laboratories
• Academic Institutes

Plasma Fractionation Market, by Geography

• North America
• U.S.
• Canada
•  
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe (RoE)
•  
• Asia-Pacific (APAC)
• China
• Japan
• India
• Rest of APAC (RoAPAC)
•  
• Latin America
• Middle East & Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5117

Spirulina Market Worth $629.6 Million by 2025

 

Meticulous Research® in collaboration with the European Algae Biomass Association (EABA), published a new market research report titled, “Spirulina Market by Distribution Channel (Consumer Channel, Business Channel), Product Type (Powder, Tablets, Capsules, Flakes, Phycocyanin Extract), and Application (Nutraceuticals, Food & Beverages, Agriculture, Animal Feed)- Global Forecast to 2025”. Combining Meticulous Research®’s market intelligence services with EABA’s broad expertise in the development of research, technology, and industrial capacities in the field of spirulina, the two organizations have leveraged their research capabilities to come up with the most reliable and accurate market assessments in this field.

According to the report, the global spirulina market is expected to grow at a CAGR of 9.4% from 2019 to reach $629.6 million by 2025. In terms of volume, the spirulina market is expected to grow at a CAGR of 13.6% from 2019 to reach 68,025.2 tons by 2025.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5070

The growth of the spirulina market is mainly attributed to growing health & wellness trends and dietary supplements industry, growing demand for natural food colors, increasing vegetarianism, and growing malnutrition. Moreover, factors such as stringent regulations regarding the inclusion of synthetic colors and flavors; increasing preference for spirulina sourced products, especially pigments and omega-3 fatty acids; growing use of spirulina in aquaculture diets; and increase in number of products that include spirulina as ingredients across the globe further support the growth of the global spirulina market.

Spirulina is very sensitive to different frameworks and its price depends on the various factors such as quantity, drying process, form, packaging, certification, origin, quality/contamination, negotiation capacity, and specific spirulina (if enriched with selenium, it is more expensive). The prices have dropped in the last few years, as the production systems have become scalable; however, production costs are still high in developed countries as compared to emerging countries due to unfavorable climatic conditions and the use of expensive production technologies.

The global spirulina market study presents historical market data in terms of value (2017 and 2018), estimated current data (2019), and forecasts for 2025-by distribution channel (consumer channel, business channel), product type (powder, tablets, capsules, flakes, and phycocyanin extract), and application (nutraceuticals, food & beverages, agriculture, animal feed, and cosmetics). The study also evaluates industry competitors and analyzes the market at a regional and country level.

The key players operating in the global spirulina market are Earthrise Nutritional, LLC (U.S.), DIC Corporation (Japan), Yunnan Green A Bio-engineering Co., Ltd (China), Algene Biotech (India), Tianjin Norland Biotech Co., Ltd. (China), Pondicherry Spirulina Farms (India), Cyanotech Corporation (U.S.), E.I.D. Parry (I) Ltd. (India), Far East Bio-Tec. Co. Ltd. (China), Fuqing King Dnarmsa Spirulina Co., Ltd. (China), Dongtai City Spirulina Bio-engineering Co., Ltd. (China), and Australian Spirulina (Australia) among others.

Browse key industry insights spread across 263 pages with 195 market data tables & 55 figures & charts from the market research report: https://www.meticulousresearch.com/product/spirulina-market-5070/

Pharmaceutical Storage and Material Handling Equipment Market Worth 1,597.4 Million USD by 2023

 According to the latest publication from Meticulous Research®, the global pharmaceutical storage and material handling equipment market is expected to grow at a CAGR of 8.6% from 2018 to reach USD 1,597.4 million in 2023. The growth of this market will be driven by factors such as rapid growth of the pharmaceutical industry, increasing focus of manufacturers on reduction of production cost, government support to promote the pharmaceutical sector, growing demand of single use systems, and increasing focus towards automation in the pharmaceutical industry. However, demand for refurbished machines hamper the growth of this market. As consolidations in the pharmaceutical industry occur and more and more machines are released within companies and in the market, the ability to use available pre-owned machines is becoming more prominent. Also, many major organizations return their pharmaceutical processing machines back to the vendor for various reasons like malfunctions, speed issue etc. These returned products are tested for functionality and defects; they are hence refurbished and resold to the small setups for the manufacturing and handling of pharma products.

Request Sample Report: https://www.meticulousresearch.com/request-sample-report/?cp_id=4364

Geographically, North America commanded the largest share of the global market, mainly due to its huge pharma manufacturing sector, high adoption rate of automation in the pharmaceutical industry, innovations and advancements in bulk material handling products and technologies, and implementation of some expansions and acquisitions plans by the leading pharmaceutical storage and material handling systems manufacturers to increase production capacity.

The major players operating in this market are SERVOLiFT GmbH, Mueller GmbH, Hanningfield Process Systems Ltd., GEA Group Aktiengesellschaft, AZO GmbH + Co. KG, David Round Company, Inc, FLEXICON Corporation, Spirotech-SRD Group Ltd., VAC-U-MAX, Dietrich Engineering Consultants S.A., Volkmann, Inc, Schenck Process Holding GmbH, Coperion Capital GmbH, Matcon Ltd., Gough Econ, Inc, Guttridge Limited, and Glatt GmbH.

The transport systems market dominated the global pharmaceutical storage and material handling equipment market, mainly due to the increasing use of automated and semi-automated transport systems to meet GMP standards. This market is also expected to increase significantly during the forecast period with the growing demand for smaller lot sizes; shorter lead times; and higher quality products, especially in developing countries.

Browse in-depth report on: https://www.meticulousresearch.com/product/pharmaceutical-storage-material-handling-equipment-market/

Oilfield Services Market is Expected to Grow at a CAGR of 3.6% to Reach $171.7 Billion by 2025

 

 

Traditional oilfield services (OFS) operating models are now being completely disrupted by the technological advancements with the increasing use of internal sources of funding. In recent years, these factors have given a new edge to the entire oil industry, which now competes with additional parameters than pricing. Hence, tech advancement has helped oil & gas companies in transforming their businesses from product selling to advisory selling.

According to a new market research report “Oilfield Services Market by Type (Pressure Pumping, Oil Country Tubular Goods, Well Intervention and Coiled Tubing, Drilling and Completion Fluid, Well Completion, Seismic Testing), Location (Onshore and Offshore), and Geography — Global Forecast to 2025” published by Meticulous Research®, the oilfield services market is expected to grow at a CAGR of 3.6% from 2019 to reach $171.7 billion by 2025.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4963

The growth of the global oilfield services market is mainly attributed to the increasing adoption of technology-driven models, rising geographically dispersed operations, and increased presence in service segments such as offshore operations. However, the price war amongst the leading oil supplying countries across the globe along with the strict government regulations on E&P activities is expected to impact the revenue of this market.

List of the Key Companies Operating in the Oilfield Services Market:

• Schlumberger Limited (U.S.)
• Baker Hughes GE (U.S.)
• Halliburton Company (U.S.)
• Weatherford International, PLC (U.S.)
• China Oilfield Services Limited (COSL) (China)
• Basic Energy Services (U.S.)
• Superior Energy Services, Inc. (U.S.)
• FMC Technologies, Inc. (U.S.)
• Welltec (Denmark)
• The Weir Group PLC (U.K.)
• National Oilwell Varco (U.S.)
• Oil States International, Inc. (U.S.)
• Archer Limited (Bermuda)

Get Detailed Insights of This Research with Table of Content: https://www.meticulousresearch.com/product/oilfield-services-market-4963/

Key questions answered in the report-

• Which are the high growth market segments in terms of service type, location, and region?
• What was the historical market for oilfield services across the globe?
• What are the market forecasts and estimates for the period 2019–2025?
• What are the major drivers, restraints, and opportunities in the global oilfield services market?
• Who are the major players in the global oilfield services market?
• How is the competitive landscape and who are the market leaders in the global oilfield services market?
• What are the recent developments in the global oilfield services market?
• What are the different strategies adopted by the major players in the global oilfield services market?
• What are the geographical trends and high growth regions?
• Who are the local emerging players in the global oilfield services market and how do they compete with the global players?

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=4963